Plato Investment Management LTD Neurocrine Biosciences Inc Transaction History
Plato Investment Management LTD
- $1.23 Trillion
- Q3 2024
A detailed history of Plato Investment Management LTD transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Plato Investment Management LTD holds 10,973 shares of NBIX stock, worth $1.51 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
10,973
Previous 425
2481.88%
Holding current value
$1.51 Million
Previous $58.5 Million
2058.66%
% of portfolio
0.1%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding NBIX
# of Institutions
626Shares Held
94MCall Options Held
632KPut Options Held
621K-
Black Rock Inc. New York, NY14.2MShares$1.96 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.38 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$710 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.57MShares$355 Million0.47% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$257 Million3.62% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.2B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...